Place the Title here
Our CATALYST initiative is an online resource designed to provide clinicians and patients with the latest information on advanced cutaneous squamous cell carcinoma (cSCC) and basal cell carcinoma (BCC). The advent of more targeted immunotherapeutic approaches has transformed patient care, leading to better disease control and significant improvement in quality of life. Our objective is to provide clinicians and patients with essential information, foster informed discussion about treatment options, and enhance the overall standard of care for those affected by advanced skin cancers.
Please explore the Clinician and Patient portals for cutting-edge information on present and evolving treatments for BCC and cSCC.
Basal Cell Carcinoma
Basal cell carcinoma (BCC), particularly advanced BCC, can be associated with complex management and poor outcomes. However, therapeutic advancements have enhanced strategies for patient-specific care.
Basal Cell Carcinoma
As a patient, it is essential to take charge of your treatment journey for basal cell carcinoma (BCC). Active involvement in the process ensures that you fully understand your condition and treatment options, enables you to feel more in control and potentially improves outcomes.
Cutaneous Squamous Cell Carcinoma
Cutaneous squamous cell carcinoma (cSCC), particularly advanced cSCC, can be associated with complex management and poor outcomes. However, therapeutic advancements have enhanced strategies for patient-specific care.
Cutaneous Squamous Cell Carcinoma
Active involvement in your treatment for cutaneous squamous cell carcinoma (cSCC) is crucial. Being informed about your condition, treatment options, and the roles of your healthcare team enables you to make better decisions about your care.
This activity is provided by Med Learning Group.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.